Gene therapy, a promising treatment for vascular disease, requires appropriate gene vectors with high gene transfer efficiency, good biocompatibility and low cytotoxicity. To satisfy these requirements from the approach of nonviral vectors, a novel block copolymer, poly 
Introduction
Local gene delivery is a promising approach for the treatment of refractory vascular disease. Previous studies have presented a variety of strategies for transferring therapeutic genes to the vascular wall.
1,2 Viral vectors, such as adenovirus vector, have been commonly utilized in these strategies, because the gene transfer efficiency with a viral vector is generally higher than that by other nonviral methods. However, the clinical use of viral vectors has considerable limitations with respect to safety. 3, 4 For therapeutic application of gene delivery to the vascular wall, it is, therefore, desirable to develop a nonviral vector with safety and reasonable efficiency of gene transfer.
Several cationic polymers (polycations), which form a polyion complex with DNA (polyplex) and then promote introduction of the DNA into cells, have been widely used as nonviral vectors in several studies in vitro. 5, 6 However, positively charged polyplexes might potentially induce cytotoxicity and form aggregates in biological media containing plasma proteins, indicating that in vivo applications of such polyplexes might be markedly restricted. 7, 8 To resolve this issue, we recently designed biocompatible nonviral vectors constructed from newly synthesized cationic block copolymer. 9 The block copolymer thus synthesized is characterized by tandem alignment of a hydrophilic poly(ethylene glycol) (PEG) segment and a cationic polyaspartamide segment carrying an ethylenediamine unit at the side chain (PEG-b-P[Asp(DET)]) (Figure 1a) , 10 leading to the formation of stable and biocompatible polyplex micelles with a core of tightly packed plasmid DNA (pDNA) surrounded by a dense shell layer of PEG (Figure 1b) . Because of the hydrophilicity as well as the strong steric-repulsive propensity of the PEG shell, the polyplex micelles are assumed to be stable in physiological entities including harsh in vivo conditions. 11 Furthermore, after internalization of the polyplex micelles into cellular compartments through the endocytic pathway, the ethylenediamine unit in the block copolymer is expected to facilitate efficient translocation of the micelle toward the cytoplasm due to the proton sponge mechanism based on its high buffering capacity. 12 A previous study indeed revealed that polyplex micelles made from PEG-b-P[Asp(DET)] accomplished appreciably high gene transfection efficacy with remarkably low cytotoxicity toward several cultured cell lines as well as primary osteoblasts. 10 In the present study, the utility of the polyplex micelle from PEG-b-P[Asp(DET)] for transfection to vascular lesions was investigated to evaluate its feasibility for vascular gene therapy. The polyplex micelle was revealed to have excellent colloidal stability even in proteinaceous medium and reduced interactions with blood components, showing appreciable gene transfection efficacy toward primary vascular smooth muscle cells (VSMC) under in vitro conditions. Furthermore, in vivo transfection of a reporter gene to rabbit carotid artery with induced neointimal lesions was successfully done, with high transfection ability and markedly reduced cytotoxicity and thrombogenicity of the polyplex micelles, making it feasible for vascular gene therapy.
Results

In vitro gene transfer to VSMC
The gene expression efficacy was evaluated as expressed luciferase activity. Expression pDNA containing the luciferase gene (pCAccluc+) was transferred to cultured VSMC using the polyplex micelle from PEG-b-P[Asp(DET)] to assess the gene transfection efficiency of the micelle from the activity of expressed luciferase after 48 h of culture. Polyplexes from branched polyethyleneimine (BPEI) and P[Asp(DET)] were used as controls. Note that P[Asp(DET)] is the homopolymer of Asp(DET), and was selected as a control to estimate the effect of PEG on physicochemical and biological characteristics of the polyplexes. Polyplexes of BPEI and P[Asp(DET)] as well as polyplex micelles of PEG-b-P[Asp(DET)] were prepared by mixing the corresponding polymer with pDNA at various N/P ratios. Here, N/P ratio refers to the unit molar ratio of the amino group in the polymer to the phosphate group in the pDNA. BPEI polyplex showed maximum transfection at an N/P ratio of 16 ( Figure 2 ), followed by a steep decrease in efficacy, presumably due to increased cytotoxicity, as shown in Figure 3 . Notably, VSMC transfected with P[Asp(DET)] polyplex and PEG-b-P[Asp(DET)] polyplex micelle maintained appreciably high luciferase activity at a wide range of N/P ratios 48, consistent with their lowered cytotoxicity ( Figure 3 ). P[Asp(DET)] polyplex achieved more than tenfold higher -(OC H 2 CH 2 )-CH 2 -NH--CO-CH-NH-/ -CO-CH 2 -CH-NH--C -CH 3   C   NH   O   CH 2   NH   CH   NH   C   NH   O   CH 2   NH   CH   NH   n   2   2   2   2   2   2 
Cytotoxicity to VSMC
Cytotoxicity to VSMC of the polyplexes and the polyplex micelles with varying N/P ratios was evaluated by MTT assay after 48 h of incubation. The viability of cells incubated with BPEI polyplex decreased linearly with an increase in N/P ratio, as seen in Figure 3 . In contrast, cellular viability remained at more than 70 and 90% even after 48 h incubation with P[Asp(DET)] polyplex and PEG-b-P[Asp(DET)] polyplex micelle, respectively, up to an N/P ratio of 64.
Aggregate formation in albumin solution
To assess the colloidal stability of the polyplexes in biological media, they were subjected to measurements of particle size and z-potential after incubation for 1 h in phosphate-buffered saline (PBS) containing various concentrations of albumin. The polyplex micelle prepared at N/P ¼ 40 maintained a size of approximately 110 nm regardless of albumin concentration, as summarized in Table 1 , yet polyplexes from both BPEI (N/P ¼ 10)
and P[Asp(DET)] (N/P ¼ 40) exhibited a marked increase in particle size in medium containing albumin at 1-2 mg/ml. The polyplexes from BPEI and P[Asp(DET)] showed highly positive z-potential values (B26 mV) in the absence of albumin, whereas their z-potential values decreased toward a neutral value with an increase in albumin concentration, presumably due to the association with anionically charged albumin molecules ( Figure 4 ). This nonspecific association with albumin is likely to be the reason for the aggregate formation of the polyplex system in the presence of albumin observed in Table 1 . In contrast, the polyplex micelle had an almost neutral z-potential with a small absolute value over a wide range of albumin concentrations (Figure 4 ), indicating improved colloidal stability of the polyplex micelle compared to conventional polyplexes with a cationic nature.
Measurement of platelet aggregation using plateletrich plasma
It is known that platelet aggregation plays a pivotal role in the initial stage of the thrombus formation. To estimate the thrombogenicity of the polyplexes and micelles, they were mixed with platelet-rich plasma (PRP), and the platelet aggregation was evaluated by a laser-scattering aggregometer PA-200 (Kowa, Tokyo, Japan). In this measurement, aggregate formation was measured as an increase in the light-scattering intensity (LSI; in mV). The size of detected aggregates was tentatively defined by LSI and was classified as 'small', 'medium' and 'large' as Abbreviations: BPEI, branched polyethyleneimine; ND, not determined; PEG, poly(ethylene glycol).
a Not determined because of aggregate formation. 
Erythrocyte aggregation assay
To further study the interaction between the polyplexes and blood cells, erythrocyte aggregation assay was carried out. It is known that erythrocytes possess negative surface charge and interact with positively charged nano-particles, resulting in the aggregate formation. 13 Erythrocytes were harvested from blood of rabbit, followed by washing and suspension with Ringer's solution to avoid the effect of serum proteins. 
Gene transfer to injured rabbit carotid artery
Rabbit carotid artery was injured with a Fogarty balloon catheter to induce neointimal hyperplasia. Twenty-one days later, BPEI (N/P ¼ 10) polyplex, P[Asp(DET)] (N/P ¼ 40) polyplex, and PEG-b-P[Asp(DET)] (N/P ¼ 40) micelle were administered into the carotid artery with neointimal involvement and incubated by cessation of arterial blood flow for 20 min. N/P ratios of the polyplexes and micelles used for in vivo experiments were adjusted to the appropriate values based on the results of in vitro experiments, that is, the balance between the cytotoxicity ( Figure 3 ) and the transfection efficiency ( Figure 2 ). Note that the aggregation assay using albumin (Table 1 and Figure 4 ), platelets ( Figure 5 ) and erythrocytes ( Figure 6 ) revealed that PEG-b-P[Asp(DET)] micelle had minimal interaction with these biocomponents at any N/P ratios. The entrapped pDNA in the polyplex and the micelle was the expression plasmid vector containing the luciferase gene (pCAccluc+). Naked pDNA (pCAccluc+) was applied in the same manner as controls. At 3 days after the treatment, the carotid arteries were sampled to assess luciferase activity in each layer of the arterial wall (Figure 7a) . All of the rabbits that received naked pDNA (n ¼ 8) or the polyplex micelle (n ¼ 8) had 100% patency of the carotid artery, whereas considerable To confirm in vivo gene transfer to the arterial wall, the expression pDNA containing the FLAG sequence (pMP-FLAG) was then complexed with PEG-b-P[Asp(DET)] and administered to the carotid artery in the same manner. The artery was harvested on day 3, and a cross section of the artery was stained with anti-FLAG antibody. The immunostain clearly showed abundant FLAG-positive cells in the arterial wall, in which FLAG expression was predominantly observed in the neointima (Figure 8a ). The pDNA expressing LacZ gene (pCAZ3) was then complexed with PEG-b-P[Asp(DET)] and administered to the carotid artery in the same manner as negative control. Eventually, the immunostain with anti-FLAG antibody showed no FLAG-positive cells (Figure 8b ) in the control specimen.
Discussion
Vascular lesions as feasible targets for gene therapy are generally related to atherosclerosis or its associated diseases. As such lesions develop from the intimal layer of the vascular wall, the intima is a primary target of vascular gene therapy, indicating that delivery via the vessel lumen is the most appropriate approach for efficient gene transfer to vascular lesions. Fortunately, it is easy to approach the luminal surface using a catheterbased method, and several endovascular devices have been developed for this purpose in previous studies. In the vessel lumen, however, attention must be paid to interactions between the gene vector and blood components such as plasma proteins and blood cells. In particular, platelet activation and aggregation promote the coagulant and fibrinolytic pathways through activation of coagulation factors accompanying aggregation of blood cells, resulting in thrombus formation. Most nonviral gene vectors possess a positively charged component in their structure to form a complex with DNA. As blood components ordinarily carry a negative Gene transfer to vascular lesions D Akagi et al charge, there is a possibility for a nonviral vector to undergo aggregation with plasma proteins and blood cells. 5, [13] [14] [15] [16] Such aggregation around a gene vector might interfere with the process of gene transfer and also induce thrombus formation, which could worsen the clinical status of the primary disease. Additionally, the positive charge of the gene vector would potentially promote cytotoxic reactions in the lesion and its surrounding part of the vascular wall. As the intima is the most accessible part in vascular gene therapy, as described, the toxic side effects derived from constituent polycations of polyplexes also predominantly appear in the intimal layer of the arterial wall, which might imply injury of intimal cells. In previous studies investigating the mechanisms of atherogenesis, various evidence has been presented to demonstrate that vascular injury is a potent trigger for lesion formation. 17, 18 Injury to the vascular wall possibly promotes a variety of responses, such as expression of adhesive molecules and receptors on vascular cells, release of several growth factors, platelet adhesion on the luminal surface and infiltration of inflammatory cells. 19 These responses might influence each other, and potentially induce the formation of neointimal hyperplasia and atherosclerotic lesions. Thus, minimal vascular injury with biocompatible gene vector systems with low cytotoxicity should be achieved for safe and reliable gene therapy in vascular diseases.
To achieve successful gene delivery to the carotid artery by intravascular method, polyplex micelles, in which the polyplex core is covered with PEG palisades, were used in this study. One of the advantageous characteristics of polyplex micelles with a PEG shell layer is high colloidal stability in a physiological proteinaceous medium, showing reduced interactions with blood components. It was reported that the thrombus formation are caused by nonspecific interaction between blood components and cationic materials such as polyplexes and prosthesis for intravascular application. [13] [14] [15] [16] [20] [21] [22] [23] [24] Srinivasan et al. 20 reported that positively charged prosthetic materials are highly thrombogenic. PEG is the well-known materials with hydrophilic character showing the high biocompatibility and the low thrombogenicity. [25] [26] [27] There are previous reports that the surface modification of biomaterials with PEG appreciably reduces thrombogenicity. 25, [28] [29] [30] [31] [32] Thus, it is widely accepted that PEG shields the cationic surface of biomaterials, reducing their thrombogenicity. 31 In this study, the PEG-b-P[Asp(DET)] micelle system showed no agglomeration even in the presence of blood components including serum albumin (Table 1 and Figure 4 ), platelets ( Figure 5 ) and erythrocytes ( Figure 6 ), whereas BPEI and P[Asp(DET)] polyplexes definitely showed the aggregate formation due to their positively charged character under the same conditions. It should be noted that PEG-b-P[Asp(DET)] micelle showed no platelet and erythrocyte aggregation even at a high N/P ratios, whereas P[Asp(DET)] and BPEI polyplexes induced platelet and erythrocyte aggregation even at low N/P ratios, such as 5. These results suggest that the surface modification of polyplexes with PEG might prevent their interaction with blood components even at a high N/P ratio required for the effective gene transfection. In addition to the colloidal stability of nonviral vectors with reduced interactions with blood components, another critical issue is the incidence of cytotoxic reactions. 
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In this regard, the lower cytotoxicity of PEG-b-P[Asp(DET)] as compared to BPEI against VSMC, a primary target of vascular gene therapy of atherosclerosis, was demonstrated in Figure 3 . Such reduced nonspecific interactions with blood components and low cytotoxicity of polyplex micelles should be the remarkable advantages as the system utilized for in vivo nonviral gene delivery via the vascular lumen. Indeed, an in vivo study using rabbit carotid artery revealed no occlusion after intraluminal delivery of the polyplex micelle made from PEG-b-P[Asp(DET)], whereas the use of polyplexes from BPEI and P[Asp(DET)] resulted in the considerable thrombo-occlusion ( Figure 7) . The efficiency of in vivo gene transfer is the most important issue in the development of gene vectors for vascular diseases, and the choice of experimental model is crucial for obtaining proper evidence of vascular gene transfer. Experimental studies commonly employ small mammals as animal models, and the artery of such small animals preserves its normal structure even in the adult. In these arteries, because the intima consists of an endothelial monolayer, gene vectors might mainly distribute to the endothelium and medial SMC after administration via the vessel lumen. However, the intimal lesion is the principal target in most vascular gene therapy, and the major cell components of the lesion are intimal SMC and macrophages. 33 Previous studies using an arterial injury model have demonstrated several biological differences between medial SMC and intimal SMC. 33 Also in gene delivery, Guzman et al. 34 showed that adenovirus-mediated gene transfer to intimal SMC was highly efficient as compared with that to medial SMC. These findings suggest that the evaluation of vascular gene transfer must be carried out on diseased artery, not normal artery. In the present study, we first induced neointimal hyperplasia in the rabbit carotid artery, and then applied gene vectors to the same artery, which mimicked vascular gene delivery in the clinical setting. Because of the proper preparation of the model, it is expected to provide highly reliable data. In this study, the evaluation using this model showed that gene delivery with the BPEI, P[Asp(DET)], and PEG-b-P[Asp(DET)] systems all promoted marked expression of the transferred gene in the neointima, media and adventitia, which was significantly greater than that after the treatment with naked pDNA. In these findings, an interesting feature is that the in vivo gene expression level after PEG-b-P[Asp(DET)] micelle treatment was similar to that after BPEI or P[Asp(DET)] polyplex treatment (Figure 7a In conclusion, polyplex micelles from PEG-b-P[Asp(DET)] showed excellent colloidal stability with reduced nonspecific interactions with blood components and had a unique feature of the lowered in vitro cytotoxicity compared to the conventional polyplexes prepared from BPEI. They achieved efficient gene transfer to the rabbit carotid artery with neointimal hyperplasia without any vascular occlusion, whereas intraluminal delivery of BPEI and P[Asp(DET)] polyplexes induced thrombus formation. Note that the polymerization degree of the polycation segment in the block copolymer is one of the determining factors for the physicochemical property of the polyplex micelles. Block copolymers with relatively shorter polycation segments are not able to form stable polypexes, 35 whereas an increase in the polymerization degree of the polycation segment results in the decreased density of PEG palisades to impair the shielding effect. In this regard, P[Asp(DET)] segment with the polymerization degree of 68 was adopted in this study to construct the block copolymer used in the polyplex micelles, balancing the core stability mainly controlled by the polycation length and the high dispersivity in biological entity correlating mainly with the density of PEG palisades. Eventually, nonspecific interactions with blood components (Table 1 , Figures 5 and 6) were effectively shielded, preventing thrombus formation, although achieving appreciable gene transfection, after the intravascular administration ( Figure 7 ). Although there is still an issue of tuning the length of both PEG and P[Asp(DET)] segments in the block copolymer to further optimize the gene transfection and blood compatibility, the concept of the polyplex micelles with the polycation core of low toxicity and high buffering capacity surrounded by the dense PEG palisade was demonstrated to be feasible as nonviral gene vectors useful in the vascular gene therapy.
Materials and methods
Synthesis of block copolymer and homopolymer
The PEG-b-P[Asp(DET)] block copolymer (PEG; Mw ¼ 12 000 g/mol, polymerization degree of P[Asp(DET)]; 68) was prepared as described previously.
10 P[Asp(DET)] was synthesized from poly(b-benzyl L-aspartate) (PBLA) by modifying the synthetic method of PEG-P[Asp(DET)]. Briefly, b-benzyl-L-aspartate N-carboxyanhydride was polymerized in N,N-dimethylformamide (DMF)/ dichloromethane (1:10) at 401C by initiation from the primary amino group of n-butylamine, followed by acetylation of the N terminus to obtain PBLA. A unimodal molecular weight distribution (Mw/Mn 1.20) of PBLA was confirmed by gel permeation chromatography (columns: TSK-gel G4000HHR+G3000HHR, eluent: DMF+10 mM LiCl, T ¼ 401C, detector: refractive index). The degree of polymerization of PBLA was calculated as 98 from the 1 H NMR spectrum (data not shown). Then, the side-chain aminolysis reaction of PBLA was performed by mixing with a 50-fold excess of diethylenetriamine in DMF at 401C to obtain P[Asp(DET)]. DMF, dichloromethane, and acetic anhydride were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Plasmids
Plasmid pCAccluc+ was constructed by inserting the recombinant luciferase gene (luc+) into the pCAGGS expression vector. pCAccluc+ was utilized for all experiments in the present study except morphological Gene transfer to vascular lesions D Akagi et al evaluation. Meanwhile, plasmid pME-FLAG was constructed by inserting the FLAG tag sequence into the pME expression vector, and used for morphological assessment by immunohistochemical staining. Plasmid pCAZ3 was constructed by inserting Escherichia coli LacZ cDNA into the pCGGGS expression vector. Plasmids were grown in E. coli JM109 and purified using Qiagen EndoFree Mega Kits (Qiagen, Hilden, Germany). pDNA was dissolved separately in 10 mM Tris-HCl buffer (pH 7.4), to be 375 mg/ml.
Preparation of polyplex micelle and other polyplexes
Given amounts of PEG-b-P[Asp(DET)], P[Asp(DET)] and BPEI were dissolved in Tris-HCl buffer (10 mM, pH 7.40) separately. The concentrations of polymers, PEG-b-P[Asp(DET)], P[Asp(DET)] and BPEI were 40, 20 and 5 mg/ml respectively. The polymer solution of PEG-b-P[Asp(DET)] was added at varying concentrations and mixed to a 2-fold excess volume of pDNA solution to form polyplex micelles at various N/P ratios. Polyplex micelles were kept overnight before being subjected to evaluation. Polymer with P[Asp(DET)] or BPEI (Mw ¼ 25 kD, Sigma Chemical, MO, USA) was also mixed with pDNA at various N/P ratios to form polyplex. Each polyplex was subjected to evaluation 30 min after mixing.
In vitro gene transfer to VSMC
Human VSMC (Applied Cell Biology Research Institute, WA, USA) were seeded on 24-well culture plates and cultured in 500 ml CS-C medium (Applied Cell Biology) containing 10% serum. When the cells were in a semiconfluent condition, a solution of polyplexes (BPEI and P[Asp(DET)]) or polyplex micelle (PEG-b-P[Asp(DET)]) was added to each well (1 mg pDNA/well) (n ¼ 4, each). After 24 h of incubation, the cells were washed with PBS and incubated additionally in CS-C for 24 h. N/P ratios of the polyplexes and the micelle were adjusted to 4, 8, 16, 32, 64 and 128 . The cells were lysed in 100 ml cell culture lysis reagent (Promega, WI, USA), and luciferase activity of each lysate was quantified using a Luciferase Assay Kit (Promega). The results were expressed as relative light units (RLU) per milligram of total protein measured by bicinchoninic acid assay (Pierce, IL, USA). The experiment was repeated three times.
Cytotoxicity to VSMC
VSMC were seeded into 96-well plates and cultured in 100 ml CS-C. When the cells reached a semi-confluent condition, the polyplexes (BPEI and P[Asp(DET)]) or the micelle (PEG-b-P[Asp(DET)]) at various N/P ratios was added to each well (0.25 mg DNA/well) (n ¼ 4, each). After 24 h of incubation, the cells were washed, and cultured in CS-C for an additional 24 h. Subsequently, cell viability in each well was evaluated using MTT assay reagent (Dojindo, Kumamoto, Japan) according to manufacturer's instructions. The experiment was repeated three times.
Dynamic light-scattering and laser-Doppler electrophoresis measurements
In dynamic light-scattering (DLS) measurement, the polyplexes, BPEI (N/P ¼ 10) and P[Asp(DET)] (N/P ¼ 40), or the micelle, PEG-b-P[Asp(DET)] (N/P ¼ 40), were diluted in 10 mM Tris-HCl buffer (pH 7.4) to adjust the concentration of pDNA to 33.3 mg/ml (n ¼ 3, each). DLS measurement was then carried out at 2570.21C using a Zetasizer Nano ZEN3600 (Malvern Instruments, Worcestershire, UK) with a vertically polarized incident beam of 488 nm from an Ar ion laser. The scattering angle was fixed at 1731. The data were analyzed by a cumulative method to obtain the hydrodynamic diameter.
Laser-Doppler electrophoresis measurements were performed at 2570.21C using a Zetasizer Nano equipped with a He-Ne ion laser (633 nm), and the scattering angle was set at 171 (n ¼ 3, each). From the electrophoretic mobility (Z), the z-potential was calculated using the Smoluchowski equation as follows: z ¼ 4pZu/e, where u is the viscosity and e the dielectric constant of the solvent. The experiment was performed twice.
Measurement of platelet aggregation
Fresh blood from Japanese white rabbits (weight, 2.5-3.0 kg; Saitama Rabbitary, Saitama, Japan) was collected and immediately mixed with a 1:9 volume of 3.8% sodium citrate solution. PRP was isolated by centrifugation at the speed of 900 rounds per minute for 11 min at room temperature and collected as the supernatant. Aggregation of platelets in PRP with polyplexes or micelles was evaluated by a laser-scattering aggregometer PA-200 (Kowa). This instrument was reported to sensitively detect small aggregates consisting of only dozens of platelets formed under weak agonists. [36] [37] [38] [39] The LSI was measured with the PA-200 to evaluate the existence and the extent of aggregates. According to the default configuration of the PA-200, the LSI was categorized to 'small', 'medium' and 'large' corresponding, respectively, to the small aggregates (9-25 mm), medium aggregates (26-50 mm) and large aggregates (51-70 mm). The results were recorded on a two-dimensional graph showing the time-dependent changes in the LSI. These experiments were repeated three times, and the representative data were shown as the results.
Erythrocyte aggregation assay
Fresh blood from Japanese white rabbits (weight, 2.5-3.0 kg; Saitama Rabbitary) was collected and immediately mixed with 20 ml heparin sodium. Erythrocytes were washed three times and suspended in Ringer's solution. Washed erythrocyte suspension (800 ml) was mixed with polyplex solution (400 ml) and incubated for 1 h at 371C. BPEI polyplexes (N/P ¼ 5 and 10), P[Asp(DET)] polyplexes (N/P ¼ 5, 10, 20 and 40) and PEG-b-P[Asp(DET)] micelles (N/P ¼ 5, 10, 20 and 40) were subjected to the measurement. They were all diluted in 10 mM Tris-HCl buffer (pH 7.4) to adjust the concentration of pDNA to 200 mg/ml. As a negative control, erythrocytes in 10 mM Tris-HCl buffer (pH 7.4) without polyplexes were also prepared. Aggregation of erythrocytes was evaluated under the optical microscope (Olympus, Tokyo, Japan). In all experiments, each common carotid artery received 400 ml pDNA containing solution (200 mg/ml, 80 mg pDNA). After 20 min incubation, the vector solution was flushed out for washing, and then the arterial circulation was restored. As control, one group of rabbits was treated with naked pDNA (80 mg pCAccluc+) solution in the same manner. Three days later, animals were sacrificed. Evans blue (1 ml of 5% solution) was injected intravenously to mark the neointimal layer of the artery 10 min before sacrificing the animals. Then the left common carotid artery was excised and the connective tissue around the excised artery was removed, and the artery was opened longitudinally. Under a stereomicroscope, blue-stained neointima was first isolated from the artery, and then the elastic medial layer was separated from the adventitia. Each obtained sample was homogenized and lysed in 200 ml cell culture lysis reagent, and luciferase activity of each lysate was measured as described. Gene transfer efficiency was presented as the ratio of luciferase activity to the protein content. The results were expressed as RLU/mgtotal protein.
Immunohistochemical study
To evaluate the distribution of gene expression after gene transfer with PEG-b-P[Asp(DET)] micelles, pME-FLAG was complexed with PEG-b-P[Asp(DET)] (N/P ¼ 40) and applied to rabbit carotid artery in the same manner. Three days after gene delivery, rabbits were sacrificed and subjected to perfusion fixation with 4% phosphate buffered paraformaldehyde (0.1 mol/l PO 4 buffer, pH 7.3). The carotid arteries were excised and embedded in paraffin. Cross sections (4 mm) were immunostained with a monoclonal antibody against FLAG tag (1:100, Sigma), as described previously. As a negative control, the cross sections, where PEG-b-P[Asp(DET)] (N/P ¼ 40) micelle with LacZ gene (pCAZ3) was instilled, were stained with anti-FLAG tag antibody.
Statistical analysis
All values are shown as mean7s.e.m. of biological experiments. The data of in vivo luciferase activity were shown as RLU/mg protein, analyzed by unpaired Student's t-test and considered significant at Po0.05.
